Compositions and methods for the therapy and diagnosis of ovarian cancer
CA 2427902 C · Owner: Corixa Corporation · Inventors: Fling, Steven P.; Xu, Jiangchun; Stolk, John A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods for the therapy and diagnosis of cancer particularly , ovarian cancer, are disclosed. Illustrative compositions comprise one or more ovarian tumor polypeptides, immunogenic portions thereof polynucleotides that , encode such polypeptides antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful for example, in the , diagnosis, prevention and/or treatment of diseases particularly ovarian , cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 13, 2001 and granted May 28, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.